Global In Vivo Preclinical Brain Imaging Devices Market - Industry Trends and Forecast to 2030

Description

List of Tables

The global in vivo preclinical brain imaging devices market is expected to reach USD 1,124,983.68 thousand by 2030 from USD 714,350.31 thousand in 2022, growing at a CAGR of 5.9% in the forecast period of 2023 to 2030.

Market Segmentation

Global In Vivo Preclinical Brain Imaging Devices Market, By Imaging Modality Type (MRI, PET/SPECT, CT, Optical Miniscopes, 2Photon Confocal, US, NIR Fluorescence, OCT, Bioluminescence, and Others), Application (Drug Discovery, Disease Characterization, and Toxicology), Therapeutic Area (Alzheimer's Disease, Parkinson's Disease, Oncology, and Other Therapeutic Areas), Biological Variable (BOLD, Oxygenation, Blood Flow, Microvessels, Neuronal Activity, and Soft Tissue), Temporal Format of Use (Under an Hour, Many Hours, and Longitudinal) End User (Pharma-Inhouse, CRO, Academia, and Others), Country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Switzerland, Netherlands, Turkey, Poland, Sweden, Belgium, Denmark, Finland, Norway, Rest of Europe, Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, and Rest of Middle East and Africa) - Industry Trends and Forecast to 2030.

Overview of Global In Vivo Preclinical Brain Imaging Devices Market Dynamics

Driver
Rising prevalence of neurological disorder
Restraint
Ethical and regulatory consideration
Opportunity
Rising research and development activities

Market Players

The key market players operating in the global invivo preclinical brain imaging devices market are:

Bruker
PerkinElmer Inc.
FUJIFILM Corporation
Miltenyi Biotec
Charles River Laboratories.
Hologic, Inc.
LI-COR, Inc.
MILabs B.V.
TriFoil Imaging
Berthold Technologies GmbH & Co.KG
A14R
Aspect Imaging Ltd.
Cubresa Inc.
Mediso Ltd.
MR Solutions
Spectrum Instruments Imaging

1 INTRODUCTION 25

1.1 OBJECTIVES OF THE STUDY 25
1.2 MARKET DEFINITION 25
1.3 OVERVIEW OF THE GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET 25
1.4 CURRENCY AND PRICING 26
1.5 LIMITATIONS 27
1.6 MARKETS COVERED 27

2 MARKET SEGMENTATION 29

2.1 MARKETS COVERED 29
2.2 GEOGRAPHICAL SCOPE 30
2.3 YEARS CONSIDERED FOR THE STUDY 31
2.4 DBMR TRIPOD DATA VALIDATION MODEL 32
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 35
2.6 MULTIVARIATE MODELLING 36
2.7 IMAGING MODALITY TYPE SEGMENT LIFELINE CURVE 36
2.8 MARKET END USER COVERAGE GRID 37
2.9 DBMR MARKET POSITION GRID 38
2.10 VENDOR SHARE ANALYSIS 40
2.11 SECONDARY SOURCES 41
2.12 ASSUMPTIONS 41

3 EXECUTIVE SUMMARY 42

4 PREMIUM INSIGHTS 45

4.1 PESTEL ANALYSIS 48
4.2 PORTR'S FIVE FORCES 49

5 REGULATORY FRAMEWORK 50

5.1 REGULATORY SCENARIO IN U.S. 50
5.2 REGULATORY SCENARIO IN AUSTRALIA 50
5.3 REGULATORY SCENARIO IN EUROPE 51
5.4 REGULATORY SCENARIO IN SOUTH AFRICA 51
5.5 REGULATORY SCENARIO IN BRAZIL 51

6 MARKET OVERVIEW 52

6.1 DRIVERS 54
- 6.1.1 RISING PREVALENCE OF NEUROLOGICAL DISORDERS 54
- 6.1.2 ADVANCEMENTS IN IMAGING TECHNIQUES USED IN BRAIN IMAGING 54
- 6.1.3 INCREASING ADOPTION OF IN-VIVO IMAGING SYSTEMS 55
6.2 RESTRAINTS 55
- 6.2.1 ETHICAL AND REGULATORY CONSIDERATIONS 55
- 6.2.2 HIGH COST ASSOCIATED WITH BRAIN IMAGING EQUIPMENT 55
6.3 OPPORTUNITIES 56
- 6.3.1 RISING STRATEGIC INITIATIVES BY THE KEY MARKET PLAYERS 56
- 6.3.2 RISING RESEARCH AND DEVELOPMENT ACTIVITIES 56
6.4 CHALLENGES 57
- 6.4.1 LACK OF SKILLED PROFESSIONALS DUE TO TECHNOLOGY ADVANCEMENT 57
- 6.4.2 INTEGRATION OF IMAGING DEVICES WITH OTHER TECHNOLOGIES 58

7 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE 59

7.1 OVERVIEW 60
7.2 MRI 61
7.3 PET/SPECT 62
7.4 CT 62
7.5 OPTICAL MINISCOPES 63
7.6 2 PHOTON CONFOCAL 63
7.7 US 64
7.8 NIR FLUORESCENCE 64
7.9 OCT 65
7.10 BIOLUMINESCENCE 65
7.11 OTHERS 66

8 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION 67

8.1 OVERVIEW 68
8.2 DRUG DISCOVERY 69
- 8.2.1 PRECLINICAL STUDIES 70
- 8.2.2 EARLY DRUG DISCOVERY 70
- 8.2.3 CLINICAL DEVELOPMENT 70
- 8.2.4 POST MARKET MONITORING 70
- 8.2.5 DATA REVIEW 70
8.3 DISEASE CHARACTERIZATION 70
8.4 TOXICOLOGY 71

9 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA 72

9.1 OVERVIEW 73
9.2 ALZHEIMER'S DISEASE 74
9.3 PARKINSON'S DISEASE 75
9.4 ONCOLOGY 75
9.5 OTHER THERAPEUTIC AREAS 76

10 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 77

10.1 OVERVIEW 78
10.2 BOLD 79
10.3 OXYGENATION 80
10.4 BLOOD FLOW 80
10.5 MICROVESSELS 81
10.6 NEURONAL ACTIVITY 81
10.7 SOFT TISSUE 82

11 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE 83

11.1 OVERVIEW 84
11.2 UNDER AN HOUR 85
11.3 MANY HOURS 86
11.4 LONGITUDINAL 86

12 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER 87

12.1 OVERVIEW 88
12.2 PHARMA-INHOUSE 89
12.3 CRO 90
12.4 ACADEMIA 90
12.5 OTHERS 91

13 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION 92

13.1 OVERVIEW 93
13.2 NORTH AMERICA 96
13.3 EUROPE 105
13.4 ASIA-PACIFIC 129
13.5 SOUTH AMERICA 153
13.6 MIDDLE EAST AND AFRICA 161

14 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, COMPANY LANDSCAPE 175

14.1 COMPANY SHARE ANALYSIS: GLOBAL 175
14.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 176
14.3 COMPANY SHARE ANALYSIS: EUROPE 177
14.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 178

15 SWOT ANALYSIS 179

16 COMPANY PROFILE 180

16.1 BRUKER 180
- 16.1.1 COMPANY SNAPSHOT 180
- 16.1.2 REVENUE ANALYSIS 180
- 16.1.3 COMPANY SHARE ANALYSIS 181
- 16.1.4 PRODUCT PORTFOLIO 181
- 16.1.5 RECENT DEVELOPMENT 181
16.2 PERKINELMER INC. 182
- 16.2.1 COMPANY SNAPSHOT 182
- 16.2.2 REVENUE ANALYSIS 182
- 16.2.3 COMPANY SHARE ANALYSIS 183
- 16.2.4 PRODUCT PORTFOLIO 183
- 16.2.5 RECENT DEVELOPMENT 183
16.3 FUJIFILM CORPORATION 184
- 16.3.1 COMPANY SNAPSHOT 184
- 16.3.2 REVENUE ANALYSIS 184
- 16.3.3 COMPANY SHARE ANALYSIS 185
- 16.3.4 PRODUCT PORTFOLIO 185
- 16.3.5 RECENT DEVELOPMENT 185
16.4 MILTENYI BIOTEC 186
- 16.4.1 COMPANY SNAPSHOT 186
- 16.4.2 COMPANY SHARE ANALYSIS 186
- 16.4.3 PRODUCT PORTFOLIO 187
- 16.4.4 RECENT DEVELOPMENT 187
16.5 CHARLES RIVER LABORATORIES. 188
- 16.5.1 COMPANY SNAPSHOT 188
- 16.5.2 REVENUE ANALYSIS 188
- 16.5.3 COMPANY SHARE ANALYSIS 189
- 16.5.4 PRODUCT PORTFOLIO 189
- 16.5.5 RECENT DEVELOPMENT 189
16.6 AI4R 190
- 16.6.1 COMPANY SNAPSHOT 190
- 16.6.2 PRODUCT PORTFOLIO 190
- 16.6.3 RECENT DEVELOPMENT 190
16.7 ASPECT IMAGING LTD. 191
- 16.7.1 COMPANY SNAPSHOT 191
- 16.7.2 PRODUCT PORTFOLIO 191
- 16.7.3 RECENT DEVELOPMENT 191
16.8 BERTHOLD TECHNOLOGIES GMBH & CO.KG 192
- 16.8.1 COMPANY SNAPSHOT 192
- 16.8.2 PRODUCT PORTFOLIO 192
- 16.8.3 RECENT DEVELOPMENT 192
16.9 CUBRESA INC. 193
- 16.9.1 COMPANY SNAPSHOT 193
- 16.9.2 PRODUCT PORTFOLIO 193
- 16.9.3 RECENT DEVELOPMENT 193
16.10 HOLOGIC, INC. 194
- 16.10.1 COMPANY SNAPSHOT 194
- 16.10.2 REVENUE ANALYSIS 194
- 16.10.3 PRODUCT PORTFOLIO 195
- 16.10.4 RECENT DEVELOPMENT 195
16.11 LI-COR, INC. 196
- 16.11.1 COMPANY SNAPSHOT 196
- 16.11.2 PRODUCT PORTFOLIO 196
- 16.11.3 RECENT DEVELOPMENT 196
16.12 MEDISO LTD. 197
- 16.12.1 COMPANY SNAPSHOT 197
- 16.12.2 PRODUCT PORTFOLIO 197
- 16.12.3 RECENT DEVELOPMENT 197
16.13 MILABS B.V. 198
- 16.13.1 COMPANY SNAPSHOT 198
- 16.13.2 PRODUCT PORTFOLIO 198
- 16.13.3 RECENT DEVELOPMENT 198
16.14 MR SOLUTIONS 199
- 16.14.1 COMPANY SNAPSHOT 199
- 16.14.2 PRODUCT PORTFOLIO 199
- 16.14.3 RECENT DEVELOPMENT 199
16.15 SPECTRAL INSTRUMENTS IMAGING 200
- 16.15.1 COMPANY SNAPSHOT 200
- 16.15.2 PRODUCT PORTFOLIO 200
- 16.15.3 RECENT DEVELOPMENT 200
16.16 TRIFOIL IMAGING 201
- 16.16.1 COMPANY SNAPSHOT 201
- 16.16.2 PRODUCT PORTFOLIO 201
- 16.16.3 RECENT DEVELOPMENT 201

17 QUESTIONNAIRE 202

18 RELATED REPORTS 205

LIST OF TABLES

TABLE 1 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 61
TABLE 2 GLOBAL MRI IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 61
TABLE 3 GLOBAL PET/SPECT IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 62
TABLE 4 GLOBAL CT IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 62
TABLE 5 GLOBAL OPTICAL MINISCOPES IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 63
TABLE 6 GLOBAL 2 PHOTON CONFOCAL IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 63
TABLE 7 GLOBAL US IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 64
TABLE 8 GLOBAL NIR FLUORESCENCE IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 64
TABLE 9 GLOBAL OCT IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 65
TABLE 10 GLOBAL BIOLUMINESCENCE IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 65
TABLE 11 GLOBAL OTHERS IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 66
TABLE 12 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 69
TABLE 13 GLOBAL DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 69
TABLE 14 GLOBAL DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 69
TABLE 15 GLOBAL DISEASE CHARACTERIZATION IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 70
TABLE 16 GLOBAL TOXICOLOGY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 71
TABLE 17 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 74
TABLE 18 GLOBAL ALZHEIMER'S DISEASE IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 74
TABLE 19 GLOBAL PARKINSON'S DISEASE IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 75
TABLE 20 GLOBAL ONCOLOGY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 75
TABLE 21 GLOBAL OTHER THERAPEUTIC AREAS IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 76
TABLE 22 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE, 2021-2030 (USD THOUSAND) 79
TABLE 23 GLOBAL BOLD IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 79
TABLE 24 GLOBAL OXYGENATION IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 80
TABLE 25 GLOBAL BLOOD FLOW IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 80
TABLE 26 GLOBAL MICROVESSELS IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 81
TABLE 27 GLOBAL NEURONAL ACTIVITY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 81
TABLE 28 GLOBAL SOFT TISSUE IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 82
TABLE 29 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 85
TABLE 30 GLOBAL UNDER AN HOUR IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 85
TABLE 31 GLOBAL MANY HOURS IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 86
TABLE 32 GLOBAL LONGITUDINAL IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 86
TABLE 33 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 89
TABLE 34 GLOBAL PHARMA-INHOUSE IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 89
TABLE 35 GLOBAL CRO IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 90
TABLE 36 GLOBAL ACADEMIA IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 90
TABLE 37 GLOBAL OTHERS IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 91
TABLE 38 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 95
TABLE 39 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND) 96
TABLE 40 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 96
TABLE 41 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 96
TABLE 42 NORTH AMERICA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 97
TABLE 43 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 97
TABLE 44 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE, 2021-2030 (USD THOUSAND) 97
TABLE 45 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 97
TABLE 46 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 98
TABLE 47 U.S. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 99
TABLE 48 U.S. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 99
TABLE 49 U.S. DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 99
TABLE 50 U.S. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 100
TABLE 51 U.S. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE, 2021-2030 (USD THOUSAND) 100
TABLE 52 U.S. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 100
TABLE 53 U.S. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 100
TABLE 54 CANADA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 101
TABLE 55 CANADA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 101
TABLE 56 CANADA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 101
TABLE 57 CANADA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 102
TABLE 58 CANADA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE, 2021-2030 (USD THOUSAND) 102
TABLE 59 CANADA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 102
TABLE 60 CANADA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 102
TABLE 61 MEXICO IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 103
TABLE 62 MEXICO IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 103
TABLE 63 MEXICO DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 103
TABLE 64 MEXICO IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 104
TABLE 65 MEXICO IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE, 2021-2030 (USD THOUSAND) 104
TABLE 66 MEXICO IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 104
TABLE 67 MEXICO IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 104
TABLE 68 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND) 105
TABLE 69 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 105
TABLE 70 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 106
TABLE 71 EUROPE DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 106
TABLE 72 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 106
TABLE 73 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE, 2021-2030 (USD THOUSAND) 106
TABLE 74 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 107
TABLE 75 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 107
TABLE 76 GERMANY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 108
TABLE 77 GERMANY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 108
TABLE 78 GERMANY DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 108
TABLE 79 GERMANY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 109
TABLE 80 GERMANY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND) 109
TABLE 81 GERMANY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 109
TABLE 82 GERMANY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 109
TABLE 83 FRANCE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 110
TABLE 84 FRANCE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 110
TABLE 85 FRANCE DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 110
TABLE 86 FRANCE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 111
TABLE 87 FRANCE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND) 111
TABLE 88 FRANCE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 111
TABLE 89 FRANCE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 111
TABLE 90 U.K. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 112
TABLE 91 U.K. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 112
TABLE 92 U.K. DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 112
TABLE 93 U.K. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 113
TABLE 94 U.K. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND) 113
TABLE 95 U.K. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 113
TABLE 96 U.K. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 113
TABLE 97 ITALY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 114
TABLE 98 ITALY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 114
TABLE 99 ITALY DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 114
TABLE 100 ITALY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 115
TABLE 101 ITALY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND) 115
TABLE 102 ITALY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 115
TABLE 103 ITALY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 115
TABLE 104 SPAIN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 116
TABLE 105 SPAIN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 116
TABLE 106 SPAIN DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 116
TABLE 107 SPAIN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 117
TABLE 108 SPAIN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND) 117
TABLE 109 SPAIN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 117
TABLE 110 SPAIN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 117
TABLE 111 RUSSIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 118
TABLE 112 RUSSIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 118
TABLE 113 RUSSIA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 118
TABLE 114 RUSSIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 119
TABLE 115 RUSSIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND) 119
TABLE 116 RUSSIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 119
TABLE 117 RUSSIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 119
TABLE 118 TURKEY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 120
TABLE 119 TURKEY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 120
TABLE 120 TURKEY DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 120
TABLE 121 TURKEY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 121
TABLE 122 TURKEY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND) 121
TABLE 123 TURKEY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 121
TABLE 124 TURKEY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 121
TABLE 125 BELGIUM IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 122
TABLE 126 BELGIUM IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 122
TABLE 127 BELGIUM DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 122
TABLE 128 BELGIUM IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 123
TABLE 129 BELGIUM IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND) 123
TABLE 130 BELGIUM IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 123
TABLE 131 BELGIUM IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 123
TABLE 132 NETHERLANDS IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 124
TABLE 133 NETHERLANDS IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 124
TABLE 134 NETHERLANDS DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 124
TABLE 135 NETHERLANDS IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 125
TABLE 136 NETHERLANDS IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND) 125
TABLE 137 NETHERLANDS IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 125
TABLE 138 NETHERLANDS IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 125
TABLE 139 SWITZERLAND IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 126
TABLE 140 SWITZERLAND IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 126
TABLE 141 SWITZERLAND DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 126
TABLE 142 SWITZERLAND IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 127
TABLE 143 SWITZERLAND IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND) 127
TABLE 144 SWITZERLAND IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 127
TABLE 145 SWITZERLAND IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 127
TABLE 146 REST OF EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 128
TABLE 147 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND) 129
TABLE 148 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 129
TABLE 149 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 130
TABLE 150 ASIA-PACIFIC DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 130
TABLE 151 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 130
TABLE 152 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE, 2021-2030 (USD THOUSAND) 130
TABLE 153 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 131
TABLE 154 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 131
TABLE 155 JAPAN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 132
TABLE 156 JAPAN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 132
TABLE 157 JAPAN DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 132
TABLE 158 JAPAN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 133
TABLE 159 JAPAN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND) 133
TABLE 160 JAPAN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 133
TABLE 161 JAPAN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 133
TABLE 162 CHINA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 134
TABLE 163 CHINA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 134
TABLE 164 CHINA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 134
TABLE 165 CHINA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 135
TABLE 166 CHINA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND) 135
TABLE 167 CHINA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 135

TABLE 168 CHINA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 135
TABLE 169 SOUTH KOREA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 136
TABLE 170 SOUTH KOREA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 136
TABLE 171 SOUTH KOREA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 136
TABLE 172 SOUTH KOREA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 137
TABLE 173 SOUTH KOREA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND) 137
TABLE 174 SOUTH KOREA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 137
TABLE 175 SOUTH KOREA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 137
TABLE 176 INDIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 138
TABLE 177 INDIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 138
TABLE 178 INDIA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 138
TABLE 179 INDIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 139
TABLE 180 INDIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND) 139
TABLE 181 INDIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 139
TABLE 182 INDIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 139
TABLE 183 AUSTRALIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 140
TABLE 184 AUSTRALIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 140
TABLE 185 AUSTRALIA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 140
TABLE 186 AUSTRALIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 141
TABLE 187 AUSTRALIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND) 141
TABLE 188 AUSTRALIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 141
TABLE 189 AUSTRALIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 141
TABLE 190 SINGAPORE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 142
TABLE 191 SINGAPORE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 142
TABLE 192 SINGAPORE DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 142
TABLE 193 SINGAPORE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 143
TABLE 194 SINGAPORE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND) 143
TABLE 195 SINGAPORE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 143
TABLE 196 SINGAPORE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 143
TABLE 197 THAILAND IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 144
TABLE 198 THAILAND IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 144
TABLE 199 THAILAND DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 144
TABLE 200 THAILAND IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 145
TABLE 201 THAILAND IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND) 145
TABLE 202 THAILAND IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 145
TABLE 203 THAILAND IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 145
TABLE 204 MALAYSIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 146
TABLE 205 MALAYSIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 146
TABLE 206 MALAYSIA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 146
TABLE 207 MALAYSIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 147
TABLE 208 MALAYSIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND) 147
TABLE 209 MALAYSIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 147
TABLE 210 MALAYSIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 147
TABLE 211 INDONESIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 148
TABLE 212 INDONESIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 148
TABLE 213 INDONESIA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 148
TABLE 214 INDONESIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 149
TABLE 215 INDONESIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND) 149
TABLE 216 INDONESIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 149
TABLE 217 INDONESIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 149
TABLE 218 PHILIPPINES IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 150
TABLE 219 PHILIPPINES IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 150
TABLE 220 PHILIPPINES DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 150
TABLE 221 PHILIPPINES IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 151
TABLE 222 PHILIPPINES IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND) 151
TABLE 223 PHILIPPINES IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 151
TABLE 224 PHILIPPINES IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 151
TABLE 225 REST OF ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 152
TABLE 226 SOUTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND) 153
TABLE 227 SOUTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 153
TABLE 228 SOUTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 153
TABLE 229 SOUTH AMERICA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 154
TABLE 230 SOUTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 154
TABLE 231 SOUTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE, 2021-2030 (USD THOUSAND) 154
TABLE 232 SOUTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 154
TABLE 233 SOUTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 155
TABLE 234 BRAZIL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 156
TABLE 235 BRAZIL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 156
TABLE 236 BRAZIL DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 156
TABLE 237 BRAZIL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 157
TABLE 238 BRAZIL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND) 157
TABLE 239 BRAZIL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 157
TABLE 240 BRAZIL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 157
TABLE 241 ARGENTINA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 158
TABLE 242 ARGENTINA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 158
TABLE 243 ARGENTINA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 158
TABLE 244 ARGENTINA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 159
TABLE 245 ARGENTINA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND) 159
TABLE 246 ARGENTINA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 159
TABLE 247 ARGENTINA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 160
TABLE 248 REST OF SOUTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 160
TABLE 249 MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND) 161
TABLE 250 MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 161
TABLE 251 MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 162
TABLE 252 MIDDLE EAST AND AFRICA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 162
TABLE 253 MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 162
TABLE 254 MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND) 162
TABLE 255 MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 163
TABLE 256 MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 163
TABLE 257 SOUTH AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 164
TABLE 258 SOUTH AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 164
TABLE 259 SOUTH AFRICA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 164
TABLE 260 SOUTH AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 165
TABLE 261 SOUTH AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND) 165
TABLE 262 SOUTH AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 165
TABLE 263 SOUTH AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 165
TABLE 264 SAUDI ARABIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 166
TABLE 265 SAUDI ARABIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 166
TABLE 266 SAUDI ARABIA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 166
TABLE 267 SAUDI ARABIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 167
TABLE 268 SAUDI ARABIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND) 167
TABLE 269 SAUDI ARABIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 167
TABLE 270 SAUDI ARABIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 167
TABLE 271 U.A.E. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 168
TABLE 272 U.A.E. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 168
TABLE 273 U.A.E. DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 168
TABLE 274 U.A.E. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 169
TABLE 275 U.A.E. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND) 169
TABLE 276 U.A.E. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 169
TABLE 277 U.A.E. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 169
TABLE 278 EGYPT IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 170
TABLE 279 EGYPT IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 170
TABLE 280 EGYPT DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 170
TABLE 281 EGYPT IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 171
TABLE 282 EGYPT IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND) 171
TABLE 283 EGYPT IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 171
TABLE 284 EGYPT IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 171
TABLE 285 ISRAEL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 172
TABLE 286 ISRAEL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 172
TABLE 287 ISRAEL DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 172
TABLE 288 ISRAEL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 173
TABLE 289 ISRAEL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND) 173
TABLE 290 ISRAEL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 173
TABLE 291 ISRAEL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 173
TABLE 292 REST OF MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 174

LIST OF FIGURES

FIGURE 1 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: SEGMENTATION 29
FIGURE 2 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: DATA TRIANGULATION 32
FIGURE 3 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: DROC ANALYSIS 33
FIGURE 4 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS 34
FIGURE 5 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: COMPANY RESEARCH ANALYSIS 34
FIGURE 6 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: INTERVIEW DEMOGRAPHICS 35
FIGURE 7 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: MARKET END USERS COVERAGE GRID 37
FIGURE 8 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: DBMR MARKET POSITION GRID 38
FIGURE 9 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: VENDOR SHARE ANALYSIS 40
FIGURE 10 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: SEGMENTATION 44
FIGURE 11 RISING PREVALENCE OF NEUROLOGICAL DISORDER IS EXPECTED TO DRIVE THE GROWTH OF THE GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET FROM 2023 TO 2030 45
FIGURE 12 IMAGING MODALITY TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET IN 2023 & 2030 45
FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET AND IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2023 TO 2030 46
FIGURE 14 NORTH AMERICA IS THE FASTEST-GROWING MARKET FOR GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET SERVICE PROVIDERS IN THE FORECAST PERIOD OF 2023 TO 2030 47
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET 53
FIGURE 16 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: BY IMAGING MODALITY TYPE, 2022 60
FIGURE 17 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: BY APPLICATION, 2022 68
FIGURE 18 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: BY THERAPEUTIC AREA, 2022 73
FIGURE 19 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: BY BIOLOGICAL VARIABLE, 2022 78
FIGURE 20 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: BY TEMPORAL FORMAT OF USE, 2022 84
FIGURE 21 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: BY END USER, 2022 88
FIGURE 22 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: SNAPSHOT (2022) 94
FIGURE 23 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: COMPANY SHARE 2022 (%) 175
FIGURE 24 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: COMPANY SHARE 2022 (%) 176
FIGURE 25 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: COMPANY SHARE 2022 (%) 177
FIGURE 26 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: COMPANY SHARE 2022 (%) 178